Alan K. Davis, PhD; Frederick S. Barrett, PhD; Darrick G. May, MD; et al.
open access
has audio
JAMA Psychiatry. 2021;78(5):481-489. doi:10.1001/jamapsychiatry.2020.3285
This randomized clinical trial examines the efficacy of psilocybin as an adjunct to psychotherapy and other treatments for major depressive disorder.
-
Podcast:
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
Marta M. Maslej, PhD; Toshiaki A. Furukawa, MD, PhD; Andrea Cipriani, MD, PhD; et al.
free access
JAMA Psychiatry. 2021;78(5):490-497. doi:10.1001/jamapsychiatry.2020.4564
This meta-analysis investigates the assumption of systematic variability in symptomatic response to antidepressants and assesses whether variability is associated with major depressive disorder severity, antidepressant class, or study publication year.
Daisy R. Singla, PhD; Andrea Lawson, PhD; Brandon A. Kohrt, MD; et al.
free access
JAMA Psychiatry. 2021;78(5):498-509. doi:10.1001/jamapsychiatry.2020.4556
This systematic review and meta-analysis assesses whether individuals in high-income countries with no formal training in mental health, such as lay counselors, nurses, midwives, and teachers, are effective in delivering preventive and treatment interventions to manage perinatal depression and anxiety symptoms.
Katsuhiko Hagi, PhD; Tadashi Nosaka, BSc; Dwight Dickinson, PhD; et al.
free access
has audio
JAMA Psychiatry. 2021;78(5):510-518. doi:10.1001/jamapsychiatry.2021.0015
This meta-analysis studies the association between cognitive dysfunction and cardiovascular risk factors and cognitive impairment in individuals with schizophrenia.
-
Podcast:
Association Between Cardiovascular Risk Factors and Cognitive Impairment in People With Schizophrenia
Mikaïl Nourredine, MD, MSc; Adrien Gering, MD; Pierre Fourneret, MD, PhD; et al.
free access
JAMA Psychiatry. 2021;78(5):519-529. doi:10.1001/jamapsychiatry.2020.4799
This systematic review and meta-analysis provides a quantitative synthesis of studies exploring the association between childhood attention-deficit/hyperactivity disorder and the risk of subsequent psychotic disorder.
Jasmin Wertz, PhD; Avshalom Caspi, PhD; Antony Ambler, MSc; et al.
open access
JAMA Psychiatry. 2021;78(5):530-539. doi:10.1001/jamapsychiatry.2020.4626
This cohort study uses data from the Dunedin Multidisciplinary Health and Development Study to investigate whether psychopathology is associated with the processes of accelerated aging.
Cheryl A. King, PhD; David Brent, MD; Jacqueline Grupp-Phelan, MD, MPH; et al.
free access
JAMA Psychiatry. 2021;78(5):540-549. doi:10.1001/jamapsychiatry.2020.4576
This prognostic study develops and independently validates a novel computerized adaptive screen for suicidal youth for use as a universal screen for suicide risk in medical emergency departments.
Armida Mucci, MD; Silvana Galderisi, MD; Dino Gibertoni, PhD; et al.
free access
JAMA Psychiatry. 2021;78(5):550-559. doi:10.1001/jamapsychiatry.2020.4614
This cohort study assess whether baseline illness-related variables, personal resources, and context-related factors are associated with work skills, interpersonal relationships, and everyday life skills at 4-year follow-up of a multicenter cross-sectional study involving community-dwelling persons with schizophrenia.